Purpose: To validate a novel BeadChip assay system for cystic fibrosis (CF) mutation testing using the panel of 25 ACMG recommended mutations and D1152H. Methods: DNA from 519 individuals originally ...
Genetic-based technologies offer the prospect of information to guide clinical decision-making but will also have impacts on the use of health care resources. Assessing the clinical utility of genetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results